Literature DB >> 24915891

Relationship between quantitative cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine and hospitalization in patients with heart failure.

Matthew W Parker1, Nitesh Sood, Alan W Ahlberg, Arnold F Jacobson, Gary V Heller, Justin B Lundbye.   

Abstract

PURPOSE: Hospitalization in patients with systolic heart failure is associated with morbidity, mortality, and cost. Myocardial sympathetic innervation, imaged by (123)I-meta-iodobenzylguanidine ((123)I-mIBG), has been associated with cardiac events in a recent multicenter study. The present analysis explored the relationship between (123)I-mIBG imaging findings and hospitalization.
METHODS: Source documents from the ADMIRE-HF trial were reviewed to identify hospitalization events in patients with systolic heart failure following cardiac neuronal imaging using (123)I-mIBG. Time to hospitalization was analyzed with the Kaplan-Meier method and compared to the mIBG heart-to-mediastinum (H/M) ratio using multiple-failure Cox regression.
RESULTS: During 1.4 years of median follow-up, 362 end-point hospitalizations occurred in 207 of 961 subjects, 79 % of whom had H/M ratio <1.6. Among subjects hospitalized for any cause, 88 % had H/M ratio <1.6 and subjects with H/M ratio <1.6 experienced hospitalization earlier than subjects with higher H/M ratios (log-rank p = 0.003). After adjusting for elevated brain natriuretic peptide (BNP) and time since heart failure diagnosis, a low mIBG H/M ratio was associated with cardiac-related hospitalization (HR 1.48, 95 % CI 1.05 - 2.0; p = 0.02).
CONCLUSION: The mIBG H/M ratio may risk-stratify patients with heart failure for cardiac-related hospitalization, especially when used in conjunction with BNP. Further studies are warranted to examine these relationships.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24915891     DOI: 10.1007/s00259-014-2819-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  20 in total

1.  Applied analysis of recurrent events: a practical overview.

Authors:  Jos W R Twisk; Nynke Smidt; Wieke de Vente
Journal:  J Epidemiol Community Health       Date:  2005-08       Impact factor: 3.710

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

Review 4.  Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies.

Authors:  J C Sisson; D M Wieland
Journal:  Am J Physiol Imaging       Date:  1986

5.  Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.

Authors:  M Suwa; Y Otake; A Moriguchi; T Ito; Y Hirota; K Kawamura; I Adachi; I Narabayashi
Journal:  Am Heart J       Date:  1997-03       Impact factor: 4.749

6.  Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.

Authors:  H P Brunner-La Rocca; M D Esler; G L Jennings; D M Kaye
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

Review 7.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

8.  Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.

Authors:  Michifumi Kyuma; Tomoaki Nakata; Akiyoshi Hashimoto; Kazuhiko Nagao; Hisataka Sasao; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

9.  123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Authors:  Arnold F Jacobson; John Lombard; Gopa Banerjee; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

Review 10.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 10.057

View more
  2 in total

1.  Cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions.

Authors:  Mario Petretta; Teresa Pellegrino; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-11       Impact factor: 9.236

2.  Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Tetsuya Watanabe; Takashi Morita; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Kiyomi Kayama; Daisuke Sakamoto; Kumpei Ueda; Takehiro Kogame; Yuto Tamura; Takeshi Fujita; Keisuke Nishigaki; Yuto Fukuda; Yuki Kokubu; Masatake Fukunami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-08       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.